期刊文献+

老年人血浆脂蛋白相关磷脂酶A2活性与其基因型、性别和年龄的关系 被引量:19

Correlations Between Plasma Lipoprotein-Associated Phospholipase A2 Activity And Genotype,Sex and Age
下载PDF
导出
摘要 目的研究血浆脂蛋白相关磷脂酶A2活性与脂蛋白相关磷脂酶A2基因、性别和年龄等因素的关系。方法应用聚合酶链反应技术和分光光度法,检测1867例50岁以上老年人的脂蛋白相关磷脂酶A2基因G994T的多态性及血浆脂蛋白相关磷脂酶A2活性。结果不同的脂蛋白相关磷脂酶A2基因型血浆脂蛋白相关磷脂酶A2活性差异存在显著(P<0.001),GG基因型活性最高,GT次之,TT最低;GG和GT基因型中,男性血浆脂蛋白相关磷脂酶A2活性显著高于女性(P<0.001),吸烟者酶活性显著高于不吸烟者(GG与GT基因型中分别为P<0.01和P<0.05);在GG基因型中,男性脂蛋白相关磷脂酶A2活性随年龄升高,在GT基因型中随年龄降低。结论血浆脂蛋白相关磷脂酶A2活性与基因型密切相关;男性脂蛋白相关磷脂酶A2活性高于女性,本研究中这种差异与吸烟有关;GG基因型中男性活性增高可能是一种对随年龄增长的血小板活化因子或氧化磷脂的应激反应的代偿机制,而这种代偿机制在GT中不明显。 Aim To evaluate effects of the G994T,sex,and age on the lipoprotein-Associated phospholipase A2(Lp-PLA2) activity.Methods Genotyping of the G994T was done by the allele-specific PCR.The Lp-PLA2 activity was measured using a commercial kit by the spectrophotometric method.Results The Lp-PLA2 levels were significantly higher in GG subpopulation,as compared to GT population and TT population.The Lp-PLA2 activity was correlated with sex.We found that,in men with the GG genotype,enzyme activity increased significandy with age. In contrast, plasma Lp-PLA2 activity in men with the GT genotype did not significantly increase with age. Conclusions The G994T was strongly correlated with the enzyme activity. The Lp-PLA2 activity in men was higher than that in women. Plasma PAF-AH activity may increase in response to stresses induced by PAF and: or oxidized phospholipids. This compensatory response may be attenuated or not evident in individuals with the m allele.
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第11期854-856,共3页 Chinese Journal of Arteriosclerosis
关键词 流行病学 脂蛋白相关磷脂酶A2 血小板活化因子 乙酰水解酶 单核苷酸多态性 动脉粥样硬化 影响因素 活性 Lipoprotein-associated Phospholipase A2 platelet-activating factor acetylhydrolase Single Nucleotide Polymorphisms Atherosclerosis Influencing Factors Activity
  • 相关文献

参考文献10

  • 1刘甲兴,郑兴.脂蛋白相关磷脂酶A2与动脉粥样硬化[J].中国动脉硬化杂志,2006,14(3):274-276. 被引量:14
  • 2Zalewski A, Macphee C. Role af Lipoprotein-Associated Phospholipase A2 in Atherosclerosis: Biology, Epidemiology, and Pjossible Therapeutic Target [J]. Arterioscler Thromb Vasc Biol, 2005, 25 (5): 923-931.
  • 3Ballantyne CM, Hoogeveen RC, Bang H, coressh J, Folsom AR, Heiss G, et al, Lipoprotein -associated phospholipase A2, high-sensitivity C-reactive proteinand risk for incident coronary heart disease in middle-aged men and women in theatherosclerosis risk in communities (ARIC) study [J]. Circulation, 2004, 109 (7) : 837-842.
  • 4Ballantyne CM, Hoogeveen RC, Bang H, Cotesh J, Folsom AR, Chambless LE, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J]. Arch Intent Med, 2005, 164(21): 2 479-484.
  • 5Karasawa K, Harada A, Satoh N, Inoue K, Setaka M. Plasma platelet activating factor-acetylhydrolase (PAF-AH) [ J], Prog Lipid Res, 2003, 42 (2) : 93- 114.
  • 6Staffolini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, et al. Platelet-activating factor acetyllydrolase deficiency: a missense mutation near theactive slte of an anti-inflammatory phospholipase [J]. J Clin Invest, 1996, 97 (12): 2784-794.
  • 7Zimmerman GA,McIntyre TM,Prescott SM,Stafforini DM.The latelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis[J].Crit Care Med,2002,30(Suppl 5):S294-301.
  • 8Sudhir CLINICAL REVIEW:lipoprotein-associated phospholipase A2 ,a novel infalmmatory biomarker and independent risk predictor for cardiovascular disease [J].J Clin Endocrinol Metab,2005,90(5):3100-105.
  • 9Hiramoto M,Yoshida H,Imaizumi T,Yoshimizu N,Satoh K.A mutation in plasma platelet-activating factor acetylhydrolase(Val279->Phe)is a genetic risk factor for stroke[J].Stroke,1997,28(12):2417-420.
  • 10Yamada Y, Yoshida H, Ichihara S, Imaizumi T, Satoh K, Yokota M, Correlations between plasnka platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype , age, and atherosclerosis in a Japanese population [J]. Atherosclerosis , 2000. 150 (1): 209-216.

二级参考文献21

  • 1Libby P. Inflammation and atherosclerosis[J]. Circulation,2002,105(9):1135-143
  • 2Caslake MJ, Packard CJ, Suckling KE, Holmes SD, Chamberlain P, Macphee CH. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease[J]. Atherosclerosis, 2000, 150(2):413-419
  • 3Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation[J]. J Biol Chem, 1998, 273(7):4012-020
  • 4Tselepis AD, Karabina SA, Stengel D, Piedagnel R, Chapman MJ, Ninio E. N-linked glycosylation of macrophagederived Lp-PLA2 is a major determinant of enzyme association with plasma HDL[J]. J Lipid RES, 2001, 42(42):1645-654
  • 5Kosaka T, Yamaguchi M, Miyanaga K, Mizuno K. Serum platelet-activating factor acetylhydrolase (LP-PLA2) activity in more than 3000 healthy Japanese [J[. Clin Chim Acta, 2001,312(1-2):179-183
  • 6Blankenberg S, Stengel D, Rupprecht HJ, Bickel C, Perret C, Rupprecht HJ, et al. Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis[J]. J Lipid Res, 2003, 44(7):1381-386
  • 7Blake GJ, Dada N, Fox JC Manson JE, Ridker PM. A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women[J]. J Am Coll Cardiol, 2001, 38(5): 1302-306
  • 8Theilmeier G, De Geest B, Van Veldhoven PP, Stengel D, Michiels C, Lox M, et al. HDL-associated LP-PLA2 reduces endothelial adhesiveness in apoE-/mice[J]. FASEB J, 2000,14(13):2032-039
  • 9Quarck R, De Geest B, Stengel D, Mertens A, Lox M, Theilmeier G, et al. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents ijuryinduced neointima formtion and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice[J]. Circulation, 2001, 103(20):2495-500
  • 10Noto H, Hara M, Karasawa K, Iso-ON, Satoh H, Togo M, et al. Human plasma platelet-activating factor acetylhydrolase binds to all murine lipoproteins, conferring protection against oxidative stress[J]. Arterioscler Thromb Vasc Biol, 2003, 23(5):829-835

共引文献13

同被引文献241

引证文献19

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部